V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
N
NVOAI Stock Diagnostic Report

Novo Nordisk tests low-dose Wegovy pill in new study

Novo Nordisk has initiated a low-dose clinical trial for the Wegovy obesity treatment pill, aiming to diversify treatment options.

View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

NVO Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-27 08:39:50NVO45RowView Report →
2026-08-19 09:05:20NVO65MidView Report →
2026-08-13 15:30:50NVO50RowView Report →
View Full History for NVO (Blueprint) →